Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms
Annals of Laboratory Medicine · 2025
DOI: 10.3343/alm.2024.0079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2025. Verfasst von Jiwon Yun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: RNA Splicing Factors, World Health Organization, Myelodysplastic Syndromes, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
ORCID-Profile: Jiwon Yun, Hye Ryoun Kim
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Yun, J., & Kim, H. R. (2025). Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.0079
Vancouver
Yun J, Kim HR. Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms. Annals of Laboratory Medicine. 2025. doi:10.3343/alm.2024.0079
BibTeX
@article{Yun2025,
author = {Yun, Jiwon and Kim, Hye Ryoun},
title = {Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53 -mutated Myelodysplastic Neoplasms},
journal = {Annals of Laboratory Medicine},
year = {2025},
doi = {10.3343/alm.2024.0079}
}
EUVIMED